Author: Dr. David Lowemann

Targeting Beta-Amyloid at the CSF: A New Therapeutic Strategy in Alzheimer’s Disease

Manuel Menendez-Gonzalez, Huber S. Padilla-Zambrano, Gabriel Alvarez, Estibaliz Capetillo-Zarate, Cristina Tomas-Zapico, Agustin Costa Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering Self-Enhancement Science for the Success of Society. With a keen interest […]

Published on April 16, 2018

Experimental Directory Structure (Exdir): An Alternative to HDF5 Without Introducing a New File Format

Svenn-Arne Dragly, Milad Hobbi Mobarhan, Mikkel E. Lepperød, Simen Tennøe, Marianne Fyhn, Torkel Hafting, Anders Malthe-Sørenssen Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering Self-Enhancement Science for the Success of Society. With […]

Published on April 14, 2018

Lower Choline and Myo-Inositol in Temporo-Parietal Cortex Is Associated With Apathy in Amnestic MCI

Shankar Tumati, Esther M. Opmeer, Jan-Bernard C. Marsman, Sander Martens, Fransje E. Reesink, Peter P. De Deyn, André Aleman Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering Self-Enhancement Science for the Success […]

Published on April 14, 2018